Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage

Journal of Infectious Diseases

Volumn 175, Issue 4, 1997, Pages 963-966

  Brew, Bruce J ^a   Pemberton, Louise ^b   Cunningham, Phillip ^b   Law, Matthew G ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

AIDS RELATED COMPLEX; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; FUNGAL MENINGITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; VIRUS DETECTION;

EID: 0030901509     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514001     Document Type: Article

References (15)

1. Brew BJ. Neurologic manifestations of HIV infection. In: Crowe S, Hoy J, Mills J, eds. Management of the HIV-infected patient. Melbourne: Cambridge University Press, 1996:109-124.
2. Shaunak S, Albright RE, Klotman ME, Henry SC, Bartlett JA, Hamilton JD. Amplification of HIV-1 provirus from cerebrospinal fluid and its correlation with neurologic disease. J Infect Dis 1990;161:1068-72.
3. Goswami KK, Miller RF, Harrison MJ, Hamel DJ, Daniels RS, Tedder RS. Expression of HIV-1 in the cerebrospinal fluid detected by the polymerase chain reaction and its correlation with central nervous system disease. AIDS 1991;5:797-803.
4. Mellors JW, Kingsley LA, Rinaldo CR, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.
5. Saag MS, Holodniy M, Kuritzkes DR, et al. HIV viral load markers in clinical practice. Nature Med 1995;2:625-9.
6. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus type 1 (HIV-1) infection. Neurology 1991;41:778-85.
7. Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis 1988;158:1079-83.
8. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994;32:292-300.
9. Eeg-Olofsson O, Link H, Wigertz A. Concentrations of CSF proteins as a measure of blood brain barrier function and synthesis of IgG within the CNS in "normal" subjects from the age of 6 months to 30 years. Acta Paediatr Scand 1981;70:167-70.
10. Brew BJ, Evans L, Byrne C, Pemberton L, Hurren L. The relationship between AIDS dementia complex and the presence of macrophage tropic and non syncytium inducing isolates of human immunodeficiency virus type 1 in the cerebrospinal fluid. J Neurovirol 1996;2:152-7.
11. Brew BJ, Rosenblum M, Cronin K, Price RW. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol 1995;38:563-70.
12. Glass JD, Wesselingh SL, Seines OA, McArthur JC. Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 1993;43:2230-7.
13. Glass JD, Fedor H, Wesselingh SL, McArthur JC. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995;38:755-62.
14. Katzenstein TL, Pedersen C, Nielsen C, Lundgren JD, Jakobsen PH, Gerstoft J. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome. AIDS 1996;10:167-73
15. O'Brien WA. Genetic and biologic basis of HIV-1 neurotropism. Res Publ Assoc Res Nerv Ment Dis 1994;72:47-70.